Proclara Biosciences
Latest round
- Series B
Last raised
- Mar 2012
Total raised
- $17M
Investors
- 2
About Proclara Biosciences
Proclara Biosciences, Inc.Founded in 2006 and headquartered in Cambridge, US, Proclara Biosciences, Inc. specializes in biopharmaceuticals aimed at neurodegenerative conditions.Proclara Biosciences, Inc. offers a range of biotechnology products focused on therapeutic interventions for neurodegenerative diseases. Their innovative solutions are designed to address the underlying mechanisms of these conditions, providing targeted treatments that aim to improve patient outcomes.The revenue model for Proclara Biosciences, Inc. is based on the sale of specialized biotech therapeutics to healthcare organizations and research facilities. Their products are available through direct sales and strategic partnerships, ensuring accessibility to healthcare professionals and researchers.Proclara Biosciences, Inc. is currently focused on expanding its portfolio of therapeutic products for neurodegenerative diseases, with several new therapies slated for launch in the coming years. This investment will be utilized for research and development efforts, enhancing their product offerings and market reach.
Who invested in Proclara Biosciences
2 investors across 2 rounds
See all investors in Proclara Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Proclara Biosciences
Who invested in Proclara Biosciences?
Proclara Biosciences has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proclara Biosciences raised?
Proclara Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Proclara Biosciences last raise money?
Proclara Biosciences's most recent round on record is a Series B, in Mar 2012.
What does Proclara Biosciences do?
Proclara Biosciences is a biotechnology company.
Where is Proclara Biosciences headquartered?
Proclara Biosciences is headquartered in Cambridge, US.
Which VCs invest in companies like Proclara Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Proclara Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Proclara Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.